LUXEMBOURG, November 10, 2025--(BUSINESS WIRE)--Regulatory News:
Eurofins Scientific SE (Paris:ERF):
Name of the Issuer | Identify code of the Issuer | Transaction day | Identify code of the financial instrument | Total daily volume (in number of shares) | Daily weighted average purchase price of the shares | Market (MIC Code) |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 03/11/2025 | FR0014000MR3 | 10 000 | 60.8433 | XPAR |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 04/11/2025 | FR0014000MR3 | 20 000 | 59.3784 | XPAR |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 05/11/2025 | FR0014000MR3 | 20 000 | 59.1337 | XPAR |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 06/11/2025 | FR0014000MR3 | 20 000 | 58.8260 | XPAR |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 07/11/2025 | FR0014000MR3 | 20 000 | 57.8278 | XPAR |
TOTAL | 90 000 | 59.0195 |
Transaction details
In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes
View source version on businesswire.com: https://www.businesswire.com/news/home/20251110963844/en/
Contacts
Eurofins Scientific SE